[Research Report] Findings of Research on Health Promotion and Working Women
date : 1/21/2016
The Japanese government has recently been increasingly focused on women in the workforce as a key component of the national growth strategy. Industry is following suit through the implementation of various initiatives, including female recruitment action plans to increase the number of women in leadership positions and numerical goals to assess government and industry efforts. However, while the momentum surrounding women in the workforce continues to grow, there has thus far been a significant lack of attention to key health aspects that are essential to supporting women’s entrance into and sustained participation in the workforce. Government-led strategies must include policies that recognize the vital importance of women’s health if empowerment of working women is truly the goal. As stakeholders consider the various policy options, discussions should include the social and economic impact that will accompany women-centered health promotion.
To support this dialogue, Health and Global Policy Institute(HGPI) in collaboration with Dr. Ataru Igarashi, Assistant Professor at The University of Tokyo’s Graduate School of Pharmaceutical Sciences, conducted research on the potential socio-economic impact of increased promotion of women’s health. This research describes women’s health and highlights current women’s health issues in Japan through international comparisons of policies related to women in the workforce and women’s health.
■Summary of Selected Results
・It is estimated that costs related to certain diseases specific to women have led to annual medical expenses and financial losses of at least 6.37 trillion JPY.
(Medical expenses: 1.42 trillion JPY. Financial losses related to absenteeism and presenteeism: 4.95 trillion JPY.)*
・There is a significant relationship between quality of life(QOL), lost working time, and decreased productivity and the presence of women’s health related health issues, including menstruation-related symptoms, breast cancer, cervical cancer, and endometriosis.
・According to study results, 20% of survey respondents visit a gynecologist regularly. More than 50% of respondents who reported not visiting a gynecologist regularly listed as their reason for not going to see a gynecologist as, “I am healthy, so there is no need to visit a gynecologist.”
・Compared to other countries, women in Japan tend to engage in gynecological cancer screening less frequently. Countries with a high rate of gynecological cancer screening offer various support services including, financial support, general practitioners who encourage patients to engage in regular medical care, and call-recall systems.**
■Policy Proposals Based on Research Findings
1. Improve Gynecologist Visitation and Screening rates
[Government(National and Local Government)]
・Add gynecological cancer screening to requirements of regular health checkups
・Provide training programs about women’s health to occupational health professionals
・Incentive physicians to provide additional consultations on women’s health
[Industry]
・Encourage and support employees to get regular health checkups, including gynecological screenings
2. Enhance Education and Advocacy Efforts
[Government(National and Local Government)]
・Provide educational programs on the human body, disease prevention and treatment, and career planning with consideration to women’s and maternal health issues
・Provide appropriate information on screening and the importance of gynecological care; provide accurate information about available options to treat menstruation-related symptoms
[Industry]
・Provide learning opportunities for both women and men about influence of hormones, women’s health issues, women’s health matters that require special consideration, the female body’s unique characteristics, and the prevention and treatment of health issues women face.
3. Promote Healthy Companies
[Government(National and Local Government)]
・Add women’s health to the list of evaluation factors within the Healthy Company Index (In Japanese, this is referred to as “Kenko-Keiei Ranking,” an initiative organized by METI.)
・Research the financial impact of women’s health on companies and survey model cases of healthy companies that prioritize women’s health
[Industry]
・Incorporate women’s health into efforts to achieve healthy companies
* The goal of this research was to discover fundamental factors that influence women’s health from a socio-economic perspective. Further studies should be conducted based on the findings of this research.
** A “call-recall system” refers to system that sends personalized notices and reminders to patients who have dropped out of care.
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)



